[O27-4] O27-4: Oncology (2)

[O27-4-4] UGT1A1 polymorphism may be a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan

Tomoko Yoshihama¹, Akira Hirasawa², Hiroyuki Nomura³, Tomoko Akahane⁴, Yoshiko Nanki⁵, Wataru Yamagami⁶, Fumio Kataoka⁷, Eiichiro Tominaga⁸, Nobuyuki Susumu⁹, Taisei Mushiroda¹⁰, Daisuke Aoki¹¹ (1.Keio University, 2.Keio University, 3.Keio University, 4.Keio University, 5.Keio University, 6.Keio University, 7.Keio University, 8.Keio University, 9.Keio University, 10.RIKEN Center for Integrative Medical Sciences, 11.Keio University)

Keywords:UGT1A1, irinotecan, ovarian cancer